PRODH2

proline dehydrogenase 2

Basic information

Region (hg38): 19:35799988-35813299

Links

ENSG00000250799NCBI:58510OMIM:616377HGNC:17325Uniprot:Q9UF12AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hydroxyprolinemia (Limited), mode of inheritance: AR

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PRODH2 gene.

  • not_specified (77 variants)
  • not_provided (4 variants)
  • PRODH2-related_disorder (4 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRODH2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000021232.2. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
2
clinvar
3
missense
73
clinvar
7
clinvar
1
clinvar
81
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 73 8 3
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PRODH2protein_codingprotein_codingENST00000301175 1113312
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.45e-130.12712544113051257470.00122
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1183143200.9810.00002043348
Missense in Polyphen85101.710.835731064
Synonymous0.2051361390.9780.000008621178
Loss of Function0.7982226.40.8320.00000148269

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006890.000678
Ashkenazi Jewish0.0002990.000298
East Asian0.001910.00190
Finnish0.006200.00616
European (Non-Finnish)0.0008820.000871
Middle Eastern0.001910.00190
South Asian0.0002690.000261
Other0.001140.00114

dbNSFP

Source: dbNSFP

Function
FUNCTION: Dehydrogenase that converts trans-4-L-hydroxyproline to delta-1-pyrroline-3-hydroxy-5-carboxylate (Hyp) using ubiquinone- 10 as the terminal electron acceptor. Can also use proline as a substrate but with a very much lower efficiency. Does not react with other diastereomers of Hyp: trans-4-D-hydroxyproline and cis- 4-L-hydroxyproline. Ubiquininone analogs such as menadione, duroquinone and ubiquinone-1 react more efficiently than oxygen as the terminal electron acceptor during catalysis. {ECO:0000269|PubMed:25697095}.;
Pathway
Arginine and proline metabolism - Homo sapiens (human);Proline catabolism;Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;Metabolism of amino acids and derivatives;Metabolism;4-hydroxyproline degradation;Glyoxylate metabolism and glycine degradation (Consensus)

Intolerance Scores

loftool
0.930
rvis_EVS
0.27
rvis_percentile_EVS
70.73

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.146
ghis
0.427

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.219

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Prodh2
Phenotype

Gene ontology

Biological process
proline catabolic process;proline catabolic process to glutamate;glyoxylate metabolic process;oxidation-reduction process
Cellular component
mitochondrion;mitochondrial inner membrane
Molecular function
proline dehydrogenase activity;oxidoreductase activity, acting on the CH-NH group of donors;FAD binding